To find out, we identified genes induced in Siglec‐14+ myeloid cells by NTHi stimulation, selected gene products quantifiable in serum, and measured their concentrations in the paired sera from COPD patients collected during exacerbation and stable phases of the disease. This evidence concerns the gene SIGLEC14 and chronic obstructive pulmonary disease.